Autres langues Biosynex

Actions

ALBIO

FR0011005933

Equipement, fournitures et distribution médicale

Marché Fermé - Euronext Paris 17:55:00 11/09/2026			Varia. 5j.	Varia. 1 janv.
0,9020 ^EUR	-5,25%		+1,12%	+51,34%

04/09	Biosynex : vote des créanciers sur le plan de sauvegarde financière
01/09	Biosynex : Thierry Paper quitte ses fonctions avec effet immédiat

Autres langues

11/06	An undisclosed buyer acquired Entire internal molecular biology business from Biosynex SA for ?4 million.
25/05	An undisclosed buyer signed a binding offer to acquire Entire internal molecular biology business from Biosynex SA for ?4 million.
07/05	Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2025
07/05	Biosynex SA Auditor Raises 'Going Concern' Doubt
30/10/25	Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2025
30/04/25	Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2024
22/01/25	Biosynex SA announced that it expects to receive ?7.987161 million in funding
03/11/24	Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2024
23/10/24	BIOSYNEX SA: CHEMBIO DIAGNOSTICS INC., A SUBSIDIARY OF BIOSYNEX, RECEIVES A GRANT FOR DEVELOPMENT OF A DPP CONGENITAL SYPHILIS ASSAY
19/07/24	Borsa di Italia: Addio a Joe?
19/07/24	Bolsa de Madrid: ¿Adiós, Joe?
29/05/24	Borsa di Italia: Nvidia sul punto di commettere un atto di lese-majeste contro Apple
29/05/24	Bolsa de Madrid: Nvidia al borde de cometer un acto de lesa majestad contra Apple
30/04/24	Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2023
29/09/23	Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2023
21/07/23	Biosynex Unit to Acquire US-based Biotech Qualigen
13/06/23	Biosynex SA acquired 57.33% interest in ProciseDx Inc. from Nestlé HealthCare Nutrition, Inc., other shareholders, employees, former employees and investors.
12/06/23	Biosynex SA signed an agreement to acquire 57.33% interest in ProciseDx Inc. from NestlÃ© HealthCare Nutrition, Inc., other shareholders, employees, former employees and investors.
08/06/23	Biosynex SA acquired Eye Care activity from LABORATOIRES INNOXA.
27/04/23	Biosynex Completes Acquisition of Chembio Diagnostics, Inc.
27/04/23	Biosynex SA completed the acquisition of Chembio Diagnostics, Inc. from Perceptive Advisors LLC and others.
21/04/23	Global markets live: EssilorLuxottica, AT&T, Tesla, Credit Suisse, Sony...
20/04/23	Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2022
13/04/23	Chembio Diagnostics Tender Offer Expiration Extended by Biosynex
13/04/23	Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.